Expand TERN Menu
TERN MENU

TERN Latest Press Releases

-- January 7, 2026 --

Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 4:05 PM

-- January 2, 2026 --

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) Globe Newswire 4:05 PM

-- December 11, 2025 --

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:05 PM

-- December 9, 2025 --

Terns Announces Pricing of Upsized $650 Million Public Offering Globe Newswire 11:30 PM
Terns Announces Proposed Public Offering Globe Newswire 6:12 AM

-- December 8, 2025 --

Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting Globe Newswire 2:45 PM

-- November 14, 2025 --

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London Globe Newswire 4:05 PM

-- November 10, 2025 --

Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates Globe Newswire 4:05 PM

-- November 4, 2025 --

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) Globe Newswire 4:05 PM

-- November 3, 2025 --

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting Globe Newswire 9:05 AM

-- October 21, 2025 --

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity Globe Newswire 4:05 PM

-- October 2, 2025 --

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) Globe Newswire 4:05 PM

-- August 21, 2025 --

Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025 Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes